← All trials
NCT02933827
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Dec 1, 2016
- Primary completion
- Aug 1, 2018
- Completion date
- Sep 1, 2018
- First posted
- —
- Last posted
- —
- Enrollment
- 36
- Arms / groups
- 3 / —
- Source
- AACT · pre-existing
Sponsors
- UnicoCell Biomed CO. LTDLead sponsor
- National Taiwan UniversityOverall official - principal investigator
- A2 Healthcare Taiwan CorporationCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.